CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: pyrrolopyrazole
Accession: CHEBI:46866
browse the term
Synonyms: related_synonym: pyrrolopyrazoles
G
Abcb4
ATP binding cassette subfamily B member 4
multiple interactions
ISO
[ABCB4 protein affects the susceptibility to LY-2157299] which affects the expression of COL1A1 mRNA; [ABCB4 protein affects the susceptibility to LY-2157299] which affects the expression of CTNNB1 protein; [ABCB4 protein affects the susceptibility to LY-2157299] which affects the expression of FN1 protein; [ABCB4 protein affects the susceptibility to LY-2157299] which affects the expression of LAMC2 protein; [ABCB4 protein affects the susceptibility to LY-2157299] which affects the expression of TGFB1 mRNA; [ABCB4 protein affects the susceptibility to LY-2157299] which affects the phosphorylation of SMAD2 protein
CTD
PMID:29808285
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Acan
aggrecan
decreases expression
EXP
LY-2157299 results in decreased expression of ACAN mRNA
CTD
PMID:29660438
NCBI chr 1:132,981,582...133,044,416
Ensembl chr 1:132,981,582...133,043,627
G
Acta2
actin alpha 2, smooth muscle
multiple interactions
ISO
LY-2157299 inhibits the reaction [[Dimethyl Sulfoxide co-treated with TGFB1 protein] results in increased expression of ACTA2 mRNA]
CTD
PMID:35366062
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Col1a1
collagen type I alpha 1 chain
multiple interactions
ISO
[ABCB4 protein affects the susceptibility to LY-2157299] which affects the expression of COL1A1 mRNA
CTD
PMID:29808285
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col1a2
collagen type I alpha 2 chain
multiple interactions
ISO
LY-2157299 inhibits the reaction [[Dimethyl Sulfoxide co-treated with TGFB1 protein] results in increased expression of COL1A2 mRNA]
CTD
PMID:35366062
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Col2a1
collagen type II alpha 1 chain
decreases expression
EXP
LY-2157299 results in decreased expression of COL2A1 mRNA
CTD
PMID:29660438
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
G
Ctnnb1
catenin beta 1
multiple interactions
ISO
[ABCB4 protein affects the susceptibility to LY-2157299] which affects the expression of CTNNB1 protein
CTD
PMID:29808285
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Fn1
fibronectin 1
multiple interactions
ISO
[ABCB4 protein affects the susceptibility to LY-2157299] which affects the expression of FN1 protein
CTD
PMID:29808285
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Lamc2
laminin subunit gamma 2
multiple interactions
ISO
[ABCB4 protein affects the susceptibility to LY-2157299] which affects the expression of LAMC2 protein
CTD
PMID:29808285
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
G
Smad2
SMAD family member 2
multiple interactions
ISO
[ABCB4 protein affects the susceptibility to LY-2157299] which affects the phosphorylation of SMAD2 protein
CTD
PMID:29808285
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
G
Smad3
SMAD family member 3
multiple interactions
EXP ISO
LY-2157299 inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]
CTD
PMID:35122773
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO EXP
[ABCB4 protein affects the susceptibility to LY-2157299] which affects the expression of TGFB1 mRNA LY-2157299 inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] LY-2157299 inhibits the reaction [[Dimethyl Sulfoxide co-treated with TGFB1 protein] results in increased expression of ACTA2 mRNA]; LY-2157299 inhibits the reaction [[Dimethyl Sulfoxide co-treated with TGFB1 protein] results in increased expression of COL1A2 mRNA]; LY-2157299 inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]
CTD
PMID:29808285 PMID:35122773 PMID:35366062
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfbr1
transforming growth factor, beta receptor 1
decreases activity
ISO
LY-2157299 results in decreased activity of TGFBR1 protein
CTD
PMID:35122773 PMID:35366062
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
G
Aatf
apoptosis antagonizing transcription factor
decreases expression
ISO
PF 3758309 results in decreased expression of AATF mRNA; PF 3758309 results in decreased expression of AATF protein
CTD
PMID:29048629
NCBI chr10:69,299,029...69,392,207
Ensembl chr10:69,299,037...69,392,201
G
Bad
BCL2-associated agonist of cell death
increases expression
ISO
PF 3758309 results in increased expression of BAD mRNA; PF 3758309 results in increased expression of BAD protein
CTD
PMID:29048629
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bak1
BCL2-antagonist/killer 1
increases expression
ISO
PF 3758309 results in increased expression of BAK1 mRNA; PF 3758309 results in increased expression of BAK1 protein
CTD
PMID:29048629
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Bax
BCL2 associated X, apoptosis regulator
decreases expression
ISO
PF 3758309 results in decreased expression of BAX protein
CTD
PMID:29048629
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
PF 3758309 results in decreased expression of BCL2 protein
CTD
PMID:29048629
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2a1
BCL2-related protein A1
decreases expression
ISO
PF 3758309 results in decreased expression of BCL2A1 mRNA
CTD
PMID:29048629
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
G
Bcl2l1
Bcl2-like 1
decreases expression
ISO
PF 3758309 results in decreased expression of BCL2L1 mRNA
CTD
PMID:29048629
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bcl2l2
Bcl2-like 2
increases expression
ISO
PF 3758309 results in increased expression of BCL2L2 mRNA
CTD
PMID:29048629
NCBI chr15:28,346,449...28,361,627
Ensembl chr15:28,356,807...28,361,624
G
Bcl6
BCL6, transcription repressor
increases expression
ISO
PF 3758309 results in increased expression of BCL6 mRNA
CTD
PMID:29048629
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
G
Bclaf1
BCL2-associated transcription factor 1
decreases expression
ISO
PF 3758309 results in decreased expression of BCLAF1 mRNA
CTD
PMID:29048629
NCBI chr 1:15,088,436...15,117,666
Ensembl chr 1:15,070,894...15,148,832
G
Bdnf
brain-derived neurotrophic factor
increases expression
ISO
PF 3758309 results in increased expression of BDNF mRNA
CTD
PMID:29048629
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Bik
BCL2-interacting killer
increases expression
ISO
PF 3758309 results in increased expression of BIK mRNA
CTD
PMID:29048629
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
G
Birc3
baculoviral IAP repeat-containing 3
decreases expression
ISO
PF 3758309 results in decreased expression of BIRC3 mRNA
CTD
PMID:29048629
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Card6
caspase recruitment domain family, member 6
decreases expression
ISO
PF 3758309 results in decreased expression of CARD6 mRNA
CTD
PMID:29048629
NCBI chr 2:54,194,343...54,206,902
Ensembl chr 2:54,195,739...54,206,846
G
Casp1
caspase 1
decreases expression
ISO
PF 3758309 results in decreased expression of CASP1 mRNA
CTD
PMID:29048629
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp6
caspase 6
decreases expression
ISO
PF 3758309 results in decreased expression of CASP6 mRNA
CTD
PMID:29048629
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Cd70
Cd70 molecule
increases expression
ISO
PF 3758309 results in increased expression of CD70 mRNA
CTD
PMID:29048629
NCBI chr 9:2,006,563...2,009,715
Ensembl chr 9:2,006,563...2,009,715
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
PF 3758309 results in increased expression of CDKN1A mRNA; PF 3758309 results in increased expression of CDKN1A protein
CTD
PMID:29048629
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cebpb
CCAAT/enhancer binding protein beta
decreases expression
ISO
PF 3758309 results in decreased expression of CEBPB mRNA
CTD
PMID:29048629
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Cryab
crystallin, alpha B
increases expression
ISO
PF 3758309 results in increased expression of CRYAB mRNA
CTD
PMID:29048629
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
G
Eda
ectodysplasin-A
increases expression
ISO
PF 3758309 results in increased expression of EDA mRNA
CTD
PMID:29048629
NCBI chr X:65,078,454...65,480,172
Ensembl chr X:65,078,673...65,480,172
G
Eef1a2
eukaryotic translation elongation factor 1 alpha 2
increases expression
ISO
PF 3758309 results in increased expression of EEF1A2 mRNA
CTD
PMID:29048629
NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071
G
Ifnb1
interferon beta 1
increases expression
ISO
PF 3758309 results in increased expression of IFNB1 mRNA
CTD
PMID:29048629
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
G
Ltb
lymphotoxin beta
increases expression
ISO
PF 3758309 results in increased expression of LTB mRNA
CTD
PMID:29048629
NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation
ISO
PF 3758309 results in decreased phosphorylation of MAPK1 protein
CTD
PMID:29048629
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
decreases phosphorylation
ISO
PF 3758309 results in decreased phosphorylation of MAPK3 protein
CTD
PMID:29048629
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8ip2
mitogen-activated protein kinase 8 interacting protein 2
increases expression
ISO
PF 3758309 results in increased expression of MAPK8IP2 mRNA
CTD
PMID:29048629
NCBI chr 7:120,526,732...120,536,982
Ensembl chr 7:120,526,732...120,536,982
G
Nfkb1
nuclear factor kappa B subunit 1
decreases expression
ISO
PF 3758309 results in decreased expression of NFKB1 mRNA
CTD
PMID:29048629
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nkx3-1
NK3 homeobox 1
increases expression
ISO
PF 3758309 results in increased expression of NKX3-1 mRNA
CTD
PMID:29048629
NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441
G
Nol3
nucleolar protein 3
increases expression
ISO
PF 3758309 results in increased expression of NOL3 mRNA
CTD
PMID:29048629
NCBI chr19:33,154,061...33,158,250
Ensembl chr19:33,154,062...33,158,250
G
Pak4
p21 (RAC1) activated kinase 4
decreases expression increases response to substance
ISO
PF 3758309 results in decreased expression of PAK4 protein PAK4 protein results in increased susceptibility to PF 3758309
CTD
PMID:29048629
NCBI chr 1:83,849,904...83,889,188
Ensembl chr 1:83,849,904...83,859,413
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
PF 3758309 results in increased cleavage of PARP1 protein
CTD
PMID:29048629
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pim2
Pim-2 proto-oncogene, serine/threonine kinase
decreases expression
ISO
PF 3758309 results in decreased expression of PIM2 mRNA
CTD
PMID:29048629
NCBI chr X:14,617,582...14,622,851
Ensembl chr X:14,617,582...14,622,851
G
Prkcz
protein kinase C, zeta
increases expression
ISO
PF 3758309 results in increased expression of PRKCZ mRNA
CTD
PMID:29048629
NCBI chr 5:165,817,786...165,930,386
Ensembl chr 5:165,819,466...165,930,367
G
Ripk2
receptor-interacting serine-threonine kinase 2
decreases expression
ISO
PF 3758309 results in decreased expression of RIPK2 mRNA
CTD
PMID:29048629
NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:29,631,570...29,662,657
G
Socs3
suppressor of cytokine signaling 3
decreases expression
ISO
PF 3758309 results in decreased expression of SOCS3 mRNA
CTD
PMID:29048629
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Stambp
Stam binding protein
decreases expression
ISO
PF 3758309 results in decreased expression of STAMBP mRNA
CTD
PMID:29048629
NCBI chr 4:116,055,563...116,083,563
Ensembl chr 4:116,056,057...116,080,543
G
Tbx3
T-box transcription factor 3
increases expression
ISO
PF 3758309 results in increased expression of TBX3 mRNA
CTD
PMID:29048629
NCBI chr12:36,879,924...36,894,849
Ensembl chr12:36,881,445...36,893,708
G
Tnfsf14
TNF superfamily member 14
increases expression
ISO
PF 3758309 results in increased expression of TNFSF14 mRNA
CTD
PMID:29048629
NCBI chr 9:2,068,295...2,073,128
Ensembl chr 9:2,069,104...2,073,216
G
Tnfsf18
TNF superfamily member 18
decreases expression
ISO
PF 3758309 results in decreased expression of TNFSF18 mRNA
CTD
PMID:29048629
NCBI chr13:73,833,478...73,907,249
Ensembl chr13:73,831,252...73,843,169
G
Tnfsf8
TNF superfamily member 8
decreases expression
ISO
PF 3758309 results in decreased expression of TNFSF8 mRNA
CTD
PMID:29048629
NCBI chr 5:77,250,942...77,277,364
Ensembl chr 5:77,251,373...77,277,421
G
Tp53i3
tumor protein p53 inducible protein 3
increases expression
ISO
PF 3758309 results in increased expression of TP53I3 mRNA
CTD
PMID:29048629
NCBI chr 6:27,818,327...27,825,753
G
Tradd
TNFRSF1A-associated via death domain
increases expression
ISO
PF 3758309 results in increased expression of TRADD mRNA
CTD
PMID:29048629
NCBI chr19:33,136,148...33,142,714
Ensembl chr19:33,136,138...33,142,638
G
Traf6
TNF receptor associated factor 6
increases expression
ISO
PF 3758309 results in increased expression of TRAF6 mRNA
CTD
PMID:29048629
NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19874
chemical entity
19872
atom
19872
nonmetal atom
19794
nitrogen atom
18974
nitrogen molecular entity
18974
organonitrogen compound
18827
organonitrogen heterocyclic compound
18148
pyrrolopyrazole
57
(3E)-N-(2,6-diethylphenyl)-3-\{[4-(4-methylpiperazin-1-yl)benzoyl]imino\}pyrrolo[3,4-c]pyrazole-5(3H)-carboxamide
0
4-(2-furanyl)-3-methyl-5-(4-methylphenyl)-2,4-dihydropyrrolo[3,4-c]pyrazol-6-one
0
4-(4-methylpiperazin-1-yl)-N-[5-(2-thienylacetyl)-1,5-dihydropyrrolo[3,4-c]pyrazol-3-yl]benzamide
0
LY-2157299
13
N-[(3E)-5-[(2R)-2-methoxy-2-phenylacetyl]pyrrolo[3,4-c]pyrazol-3(5H)-ylidene]-4-(4-methylpiperazin-1-yl)benzamide
0
PF-3758309
44
ZCAN262
0
omarigliptin
0
Path 2
CHEBI ontology
19874
subatomic particle
19872
composite particle
19872
hadron
19872
baryon
19872
nucleon
19872
atomic nucleus
19872
atom
19872
main group element atom
19811
p-block element atom
19811
p-block molecular entity
19811
carbon group molecular entity
19751
organic molecular entity
19748
organic molecule
19700
organic cyclic compound
19490
organic heterocyclic compound
18868
organic heteropolycyclic compound
18294
organic heterobicyclic compound
17237
pyrrolopyrazole
57
(3E)-N-(2,6-diethylphenyl)-3-\{[4-(4-methylpiperazin-1-yl)benzoyl]imino\}pyrrolo[3,4-c]pyrazole-5(3H)-carboxamide
0
4-(2-furanyl)-3-methyl-5-(4-methylphenyl)-2,4-dihydropyrrolo[3,4-c]pyrazol-6-one
0
4-(4-methylpiperazin-1-yl)-N-[5-(2-thienylacetyl)-1,5-dihydropyrrolo[3,4-c]pyrazol-3-yl]benzamide
0
LY-2157299
13
N-[(3E)-5-[(2R)-2-methoxy-2-phenylacetyl]pyrrolo[3,4-c]pyrazol-3(5H)-ylidene]-4-(4-methylpiperazin-1-yl)benzamide
0
PF-3758309
44
ZCAN262
0
omarigliptin
0